Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers
Mass-spectrometry-based profiling can be used to stratify tumours into molecular subtypes. Here, by classifying over 500 tumours, the authors show that this approach reveals proteomic subgroups which cut across tumour types.
Guardado en:
Autores principales: | Fengju Chen, Darshan S. Chandrashekar, Sooryanarayana Varambally, Chad J. Creighton |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bedcde693ec34da7b8d8594c194d689d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Global molecular alterations involving recurrence or progression of pediatric brain tumors
por: Fengju Chen, et al.
Publicado: (2022) -
Pan-urologic cancer genomic subtypes that transcend tissue of origin
por: Fengju Chen, et al.
Publicado: (2017) -
Comparative transcriptome analyses reveal genes associated with SARS-CoV-2 infection of human lung epithelial cells
por: Darshan S. Chandrashekar, et al.
Publicado: (2021) -
Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting
por: Wei Liu, et al.
Publicado: (2021) -
Computational mass spectrometry-based proteomics.
por: Lukas Käll, et al.
Publicado: (2011)